Any procedure where fertilisation takes place outside the body is a form of IVF.
Every month, follicles begin to develop in a woman’s ovaries. Around 1 to 30 follicles will grow each menstrual cycle – depending on a woman’s age and ovarian reserve. But just one follicle will dominate and release a mature egg.
During an IVF cycle, injections of a hormone known as FSH (follicle stimulating hormone) are used to encourage more of the follicles to develop mature eggs – which are then collected under vaginal ultrasound guidance – sometimes called oocyte (egg) pick up (OPU) or retrieval.
The eggs are then fertilised by sperm in the lab. The developing embryos are monitored for several days, in Genea’s exclusive Geri™ incubation system before one is transferred to the uterus. Patients are able to watch their embryos develop in Geri via our Grow By Genea™ app. If there are additional embryos, they can be frozen and stored for later use.
ICSI is a specialised form of IVF, commonly recommended by a Fertility Specialist if sperm numbers are low or sperm motility is poor. During ICSI our highly trained and skilled scientists use sperm microinjection to inject a single sperm directly into the cytoplasm of the egg. The sperm is selected mainly on the basis of its normal shape and size.
Once the eggs have been successfully fertilised, the resulting embryos are left to develop in the lab over the next five to six days and transferred or frozen, just as they are for a “routine” IVF cycle.
Should IVF or ICSI be required, you want to ensure that the care, technology and success are world leading to maximise your chance of a family, in the least number of cycles possible.
At Genea, our care ensures a personalised treatment plan to address your fertility issue. You are surrounded by a supportive team of counsellors, nurses and scientists. Every cycle starts with a Fertility Specialist who will go on to conduct all procedures and oversee all treatment*. Our care ensures you are stimulated at the correct time in your cycle, egg pick up is at the most appropriate time for egg quality and the medications and dosage we prescribe are tailored for you.
Technology is key when it comes to IVF, we have long pioneered fertility treatment and continue to today. Genea’s world leading incubation system has seen an increase of 46.7% in the number of high grade embryos per cycle**.
Our success rates are a result of our aspiration to do one egg and sperm collection and from this create enough embryos for patients to complete their family. At Genea, we are working towards One Cycle, One Family. Already 59% of patients who achieved a live birth and returned for a frozen transfer have had a second child with just one fresh stimulated IVF cycle***.
After all, 8 out of 10 patients who started treatment elsewhere wish they came to Genea first^.
* If your Fertility Specialist is on leave or unable to attend to your procedure, he or she will arrange for another Genea Specialist to attend. Please always check with your Specialist for times of known planned leave, before you start your cycle.
** When compared to the traditional incubator and culture medium system. Study performed at Genea’s flagship Kent Street, Sydney CBD laboratory. Data presented at Fertility Society of Australia Conference, October 2017. Adelaide.
*** 1st Stim Cycle between 01Jan12-31Dec13 (3573 patients). Following subsequent Cryos through to 31Dec15. Autologous patients only (no donor oocytes or surrogates). Sites from Kent St, Liverpool, Canberra, Norwest/Bella Vista, Illawarra. Oocyte Vitrification patients excluded.
^ Of those patients who responded to the Genea patient survey conducted between 1 January 2017 and 31 December 2017 (223 patients).